Daily Bulletin

Men's Weekly

.

Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of Individuals with Multiple System Atrophy

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of Individuals with Multiple System Atrophy

Australia now open for study of rare, rapidly progressive Parkinsonian Disorder

MELBOURNE, Australia and SAN FRANCISCO, Oct. 13, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative...

Read more: Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of...

Business News

Nutifood Partners With GippsNature for First Product Launch, Eyeing Global Growth

The Victorian Government delegation joined discussions during the visit The first GippsNature product signals a new chapter in Vietnam - Australia dairy ties. A New Cross-Border Dairy Initiative ...

Daily Bulletin - avatar Daily Bulletin

5 Tips for Maintaining Outdoor Furniture in Rentals

Think outdoor furniture is low-maintenance? Tell that to the sun, the rain, and the occasional possum that decides to test it out. If you’re managing a property, that outdoor setup isn’t just for sho...

Daily Bulletin - avatar Daily Bulletin

Finding the Best Removalists in Geelong, Victoria: What You Need to Know

Moving to a new home or office can be both exciting and stressful. The process involves a lot of planning, coordination, and effort to ensure that everything runs smoothly. One of the most important d...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business